- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory Neoplastic Post-Transplant Lymphoproliferative Disorder
Total 1883 results
-
Narendranath EpperlaNot yet recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory Mantle Cell Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Refractory Anemia With Excess BlastsUnited States
-
Stanford UniversityCompletedAmyloidosis | Blood and Marrow Transplant (BMT)United States
-
Atara BiotherapeuticsNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer CenterCompletedEBV-induced Lymphomas | EBV-associated Malignancies | Transplant Patients With EBV Viremia at High Risk of Developing a Recurrent EBV LymphomaUnited States
-
National Cancer Institute (NCI)Childrens Oncology Group (COG); LLS PedAL LLCRecruitingDown Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute Leukemia | Acute Myeloid Leukemia Post Cytotoxic Therapy | Myelodysplastic...United States
-
Shahid Beheshti University of Medical SciencesNot yet recruitingMultiple Myeloma, RefractoryIran, Islamic Republic of
-
University of PennsylvaniaGenentech, Inc.Recruiting
-
Xinqiao Hospital of ChongqingSichuan Kelun-Biotech Biopharmaceutical Co., Ltd.RecruitingMultiple Myeloma, RefractoryChina
-
OncotherapeuticsKaryopharm Therapeutics IncRecruitingRefractory Multiple MyelomaUnited States
-
Karyopharm Therapeutics IncRecruiting
-
AbbVieActive, not recruiting
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.CompletedRelapsed/Refractory Multiple MyelomaUnited States, France
-
University of Maryland, BaltimoreActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
NexImmune Inc.SuspendedRelapsed Refractory Multiple MyelomaUnited States
-
AmgenActive, not recruitingRelapsed Refractory Multiple MyelomaIndia
-
AmgenTerminatedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Japan, Germany, Netherlands, Canada
-
GWT-TUD GmbHActive, not recruitingRefractory Multiple MyelomaGermany
-
Precision BioSciences, Inc.TerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Celyad Oncology SAActive, not recruitingRelapse/Refractory Multiple MyelomaBelgium, United States
-
NanoAlvandCompletedMultiple Myeloma, Refractory
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
MiNK TherapeuticsCompletedRelapsed/Refractory Multiple MyelomaUnited States
-
Sun Yat-sen UniversityUnknownRelapsed, Refractory, Multiple MyelomaChina
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
Novartis PharmaceuticalsCompletedRelapse/Refractory Multiple MyelomaJapan
-
Henan Cancer HospitalThe Pregene (ShenZhen) Biotechnology Company, Ltd.Unknown
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States
-
Peking University People's HospitalNot yet recruitingRelapsed/Refractory Multiple MyelomaChina
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Second Affiliated Hospital of Soochow UniversityRecruitingRelapsed/Refractory Multiple MyelomaChina
-
He HuangYake Biotechnology Ltd.RecruitingRelapse/Refractory Multiple MyelomaChina
-
Ichnos Sciences SARecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia
-
Gracell Biopharmaceuticals, Inc.RecruitingRelapsed/ Refractory Multiple MyelomaUnited States
-
Caribou Biosciences, Inc.RecruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityNanjing Legend Biotech Co.Not yet recruitingRelapsed/Refractory Multiple MyelomaChina
-
Weijun FuNanjing Legend Biotech Co.RecruitingRelapsed/Refractory Multiple MyelomaChina
-
TeneoOne Inc.RecruitingRelapsed/Refractory Multiple MyelomaAustralia, Germany, Japan, Spain, United States, Italy, Poland
-
Janssen Pharmaceutica N.V., BelgiumRecruitingRelapsed/Refractory Multiple MyelomaGermany, Italy, Belgium, Spain, Netherlands, France, United Kingdom
-
Rapa Therapeutics LLCMedical College of WisconsinRecruitingRelapsed, Refractory Multiple MyelomaUnited States
-
PETHEMA FoundationRecruitingRefractory Multiple MyelomaSpain
-
SanofiActive, not recruitingRelapsed/Refractory Multiple MyelomaAustralia, Czechia, Brazil, Japan, Greece, Portugal
-
Janssen Research & Development, LLCWithdrawnRelapsed/ Refractory Multiple MyelomaUnited States, Poland
-
University of California, San DiegoTakeda; Celgene; Janssen, LPActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
GlaxoSmithKlineTerminatedRelapsed/Refractory Multiple MyelomaAustralia, Sweden, Canada
-
The First Affiliated Hospital of Soochow UniversityWithdrawnRelapsed/Refractory Multiple MyelomaChina
-
TakedaCompletedRelapsed/Refractory Multiple MyelomaJapan
-
Sara V. LatorreInstituto de Salud Carlos III; Fondos ARI (Assistencia Recerca Intensiva); Fondo...Active, not recruiting
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Ukraine, United Kingdom
-
The First Affiliated Hospital of Soochow UniversityInnovent Biologics (Suzhou) Co. Ltd.CompletedRelapsed/Refractory Multiple MyelomaChina
-
Antengene CorporationCompletedRelapse/Refractory Multiple MyelomaChina